EFFEXOR XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Effexor Xr, and what generic alternatives are available?
Effexor Xr is a drug marketed by Upjohn and is included in one NDA.
The generic ingredient in EFFEXOR XR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Effexor Xr
A generic version of EFFEXOR XR was approved as venlafaxine hydrochloride by TEVA on August 3rd, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EFFEXOR XR?
- What are the global sales for EFFEXOR XR?
- What is Average Wholesale Price for EFFEXOR XR?
Summary for EFFEXOR XR
Recent Clinical Trials for EFFEXOR XR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mit Ghamr Oncology Center | Phase 4 |
Vanderbilt University Medical Center | Phase 4 |
AbbVie | Phase 4 |
Pharmacology for EFFEXOR XR
Drug Class | Serotonin and Norepinephrine Reuptake Inhibitor |
Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Paragraph IV (Patent) Challenges for EFFEXOR XR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
EFFEXOR XR | Extended-release Tablets | venlafaxine hydrochloride | 37.5 mg, 75 mg and 150 mg | 020699 | 1 | 2007-05-03 |
US Patents and Regulatory Information for EFFEXOR XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-001 | Oct 20, 1997 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-004 | Oct 20, 1997 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-002 | Oct 20, 1997 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-003 | Oct 20, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EFFEXOR XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-001 | Oct 20, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-002 | Oct 20, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-004 | Oct 20, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | EFFEXOR XR | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699-004 | Oct 20, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EFFEXOR XR
See the table below for patents covering EFFEXOR XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovakia | 281530 | ⤷ Sign Up | |
Ukraine | 77145 | EXTENDED RELEASE DOSAGE FORMULATION | ⤷ Sign Up |
Poland | 341141 | ⤷ Sign Up | |
European Patent Office | 0797991 | Compositions de venlafaxine à libération prolongée (Extended release formulation containing venlafaxine) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for EFFEXOR XR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0112669 | 96C0002 | Belgium | ⤷ Sign Up | PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |